SCHEMBL6173776

SCHEMBL6173776

CC1(Cc2ccnc(OCc3ccccc3)c2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ITGAL P20701 1/20 0.36
AR P10275 2/20 0.36
MRGPRX4 Q96LA9 2/20 0.35
NTRK1 P04629 1/20 0.35
POLB P06746 1/20 0.35
MMP2 P08253 1/20 0.34
MMP13 P45452 1/20 0.34
MCHR1 Q99705 1/20 0.34
OPRL1 P41146 1/20 0.34
LIPE Q05469 1/20 0.34
SLC5A1 P13866 2/20 0.33
CTSD P07339 1/20 0.33
BACE1 P56817 1/20 0.33
BACE2 Q9Y5Z0 1/20 0.33
ELOVL6 Q9H5J4 1/20 0.33
ELOVL3 Q9HB03 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171047 0.89 IGF1R (0.48) IGF1RL3MBTL1RAB9AITGALAR
SCHEMBL6174192 0.87 IGF1R (0.53) IGF1RITGAL
SCHEMBL6173181 0.86 IGF1R (0.43) IGF1RL3MBTL1NPC1RAB9AITGAL
SCHEMBL6174845 0.85 NTRK1 (0.38) L3MBTL1ITGALARNTRK1POLB
SCHEMBL6175657 0.83 IGF1R (0.45) IGF1RL3MBTL1ITGALARNTRK1
SCHEMBL6173435 0.83 IGF1R (0.45) IGF1RL3MBTL1ITGALARNTRK1
SCHEMBL6176754 0.83 ITGAL (0.44) IGF1RL3MBTL1ITGALARNTRK1
SCHEMBL6177034 0.83 IGF1R (0.40) IGF1RL3MBTL1ITGALARMRGPRX4
SCHEMBL6173853 0.82 IGF1R (0.37) IGF1RL3MBTL1ITGALARPOLB
SCHEMBL6175573 0.81 ITGAL (0.39) IGF1RL3MBTL1ITGALARNTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed